SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Francesca M. Notarangelo, Ana Pocivavsek, Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior, Neuropharmacology, 2016,

    CrossRef

  2. 2
    G V Carr, J Chen, F Yang, M Ren, P Yuan, Q Tian, A Bebensee, G Y Zhang, J Du, P Glineburg, R Xun, O Akhile, D Akuma, J Pickel, J C Barrow, F Papaleo, D R Weinberger, KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia, Molecular Psychiatry, 2016,

    CrossRef

  3. 3
    Ana Pocivavsek, Francesca M. Notarangelo, Hui-Qiu Wu, John P. Bruno, Robert Schwarcz, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 2016,

    CrossRef

  4. 4
    N. Pérez Vasquez, M. Crosnier de bellaistre-Bonose, N. Lévêque, E. Thioulouse, D. Doummar, T. Billette de Villemeur, D. Rodriguez, R. Couderc, S. Robin, C. Courderot-Masuyer, F. Moussa, Advances in the metabolic profiling of acidic compounds in children’s urines achieved by comprehensive two-dimensional gas chromatography, Journal of Chromatography B, 2015, 1002, 130

    CrossRef

  5. 5
    C.M. Forrest, K. McNair, M. Pisar, O.S. Khalil, L.G. Darlington, T.W. Stone, Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine, Neuroscience, 2015, 310, 91

    CrossRef

  6. 6
    Michelle L. Pershing, David M. Bortz, Ana Pocivavsek, Peter J. Fredericks, Christinna V. Jørgensen, Sarah A. Vunck, Benedetta Leuner, Robert Schwarcz, John P. Bruno, Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: Implications for schizophrenia, Neuropharmacology, 2015, 90, 33

    CrossRef

  7. 7
    Nicole E. DeAngeli, Travis P. Todd, Stephen E. Chang, Hermes H. Yeh, Pamela W. Yeh, David J. Bucci, Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood, Frontiers in Behavioral Neuroscience, 2015, 8,

    CrossRef

  8. 8
    Jillian M. Heisler, Jason C. O’Connor, Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory, Brain, Behavior, and Immunity, 2015, 50, 115

    CrossRef

  9. 9
    Jennifer M. Parrott, Jason C. O’Connor, Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology, Frontiers in Psychiatry, 2015, 6,

    CrossRef

  10. 10
    Melissa L. Sinkus, Sharon Graw, Robert Freedman, Randal G. Ross, Henry A. Lester, Sherry Leonard, The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function, Neuropharmacology, 2015, 96, 274

    CrossRef

  11. 11
    Xi-Cong Liu, Maria Holtze, Susan B. Powell, Niccolò Terrando, Markus K. Larsson, Anna Persson, Sara K. Olsson, Funda Orhan, Magdalena Kegel, Linnea Asp, Michel Goiny, Lilly Schwieler, Göran Engberg, Håkan Karlsson, Sophie Erhardt, Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment – Role of brain kynurenic acid, Brain, Behavior, and Immunity, 2014, 36, 80

    CrossRef

  12. 12
    Ana Pocivavsek, Marian A. R. Thomas, Greg I. Elmer, John P. Bruno, Robert Schwarcz, Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats, Psychopharmacology, 2014, 231, 14, 2799

    CrossRef

  13. 13
    Katerina Zavitsanou, Chai K. Lim, Tertia Purves-Tyson, Tim Karl, Michael Kassiou, Samuel D. Banister, Gilles J. Guillemin, Cynthia Shannon Weickert, Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition, Brain, Behavior, and Immunity, 2014, 41, 173

    CrossRef

  14. 14
    Sarah Beggiato, Sergio Tanganelli, Kjell Fuxe, Tiziana Antonelli, Robert Schwarcz, Luca Ferraro, Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex, Neuropharmacology, 2014, 82, 11

    CrossRef

  15. 15
    F.M. Notarangelo, E.H. Wilson, K.J. Horning, M.A.R. Thomas, T.H. Harris, Q. Fang, C.A. Hunter, R. Schwarcz, Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia, Schizophrenia Research, 2014, 152, 1, 261

    CrossRef

  16. 16
    Keith A. Feigenson, Alex W. Kusnecov, Steven M. Silverstein, Inflammation and the two-hit hypothesis of schizophrenia, Neuroscience & Biobehavioral Reviews, 2014, 38, 72

    CrossRef

  17. 17
    Ikwunga Wonodi, Robert P. McMahon, Nithin Krishna, Braxton D. Mitchell, Judy Liu, Matthew Glassman, L. Elliot Hong, James M. Gold, Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia, Schizophrenia Research, 2014, 160, 1-3, 80

    CrossRef

  18. 18
    Aye-Mu Myint, Yong-Ku Kim, Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014, 48, 304

    CrossRef

  19. 19
    Leora Yetnikoff, Rhett A. Reichard, Zachary M. Schwartz, Kenneth P. Parsely, Daniel S. Zahm, Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat, Journal of Comparative Neurology, 2014, 522, 5
  20. 20
    C.M. Forrest, O.S. Khalil, M. Pisar, K. McNair, E. Kornisiuk, M. Snitcofsky, N. Gonzalez, D. Jerusalinsky, L.G. Darlington, T.W. Stone, Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway, Neuroscience, 2013, 254, 241

    CrossRef

  21. 21
    K.S. Alexander, A. Pocivavsek, H.-Q. Wu, M.L. Pershing, R. Schwarcz, J.P. Bruno, Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: Reversal with galantamine, Neuroscience, 2013, 238, 19

    CrossRef

  22. 22
    George Anderson, Michael Maes, Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, 42, 5

    CrossRef

  23. 23
    Hannah F. Iaccarino, Raymond F. Suckow, Shan Xie, David J. Bucci, The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia, Schizophrenia Research, 2013, 150, 2-3, 392

    CrossRef

  24. You have free access to this content24
    Trevor W Stone, L Gail Darlington, The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders, British Journal of Pharmacology, 2013, 169, 6
  25. 25
    Robert Schwarcz, John P. Bruno, Paul J. Muchowski, Hui-Qiu Wu, Kynurenines in the mammalian brain: when physiology meets pathology, Nature Reviews Neuroscience, 2012, 13, 7, 465

    CrossRef